Overexpression of CyclinA2 ameliorates hypoxia‑impaired proliferation of cardiomyocytes
- Authors:
- Published online on: August 26, 2014 https://doi.org/10.3892/etm.2014.1935
- Pages: 1513-1517
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Abstract
Hypoxia is a primary mediator for cell survival, and has been reported to inhibit cardiomyocyte proliferation in fetal and neonatal hearts. CyclinA2 is a key regulator of cell proliferation. Whether CyclinA2 affects cardiomyocyte proliferation in hypoxic conditions remains unexamined. This study was designed to investigate the roles of CyclinA2 expression on hypoxia‑impaired cardiomyocyte proliferation. Cardiomyocytes were isolated from neonatal rats and randomly separated into six groups: Control, hypoxia, enhanced green fluorescent protein (EGFP)‑Adv, EGFP‑Ccna2, EGFP‑Adv + hypoxia and EGFP‑Ccna2 + hypoxia. The cells in the control group were cultured in a general cell incubator; the cells in the hypoxia group were placed in a hypoxic chamber for 12 h; the cells in the EGFP‑Adv and EGFP‑Ccna2 groups were separately transfected with EGFP‑adenovirus capsids or EGFP‑adenovirus capsids with CyclinA2 cDNA for 18 h, and then placed in a general incubator for an additional 12 h; the cells in the EGFP‑Adv + hypoxia and EGFP‑Ccna2 + hypoxia groups were separately transfected with EGFP‑adenovirus capsids or EGFP‑adenovirus capsids with CyclinA2 cDNA for 18 h, and then placed in a hypoxia chamber for an additional 12 h. CyclinA2 expression was measured using immunochemical staining and western blot analysis, and cardiomyocyte proliferation was measured using the cell counting kit 8. GFP fluorescence indicated a high transfection efficiency (>80%), and immunochemical staining showed that CyclinA2 was mainly distributed in the nucleus. CyclinA2 expression was downregulated following exposure to hypoxia for 12 h. Cardiomyocyte proliferation was also significantly decreased following exposure to hypoxia for 12 h. However, compared with the EGFP‑Adv group, CyclinA2 expression and cardiomyocyte proliferation was markedly increased in the EGFP‑Ccna2 group. Furthermore, compared with the EGFP‑Adv + hypoxia group, CyclinA2 expression and cell proliferation were markedly increased in the EGFP‑Ccna2 + hypoxia group. These findings indicate that CyclinA2 upregulation improves cardiomyocyte proliferation in hypoxic conditions.
